Free Trial

Merck KGaA (OTCMKTS:MKGAF) Stock Passes Below Fifty Day Moving Average - Here's What Happened

Merck KGaA logo with Medical background

Key Points

  • Merck KGaA's stock has **dropped below its 50-day moving average** of $129.40, trading as low as $124.88, before bouncing back to $130.00.
  • The company has a **market capitalization of $16.80 billion** and operates within three main segments: Life Science, Healthcare, and Electronics.
  • Financial metrics include a **debt-to-equity ratio of 0.27** and a price-to-earnings ratio of 19.85, indicating a stable financial position.
  • Five stocks to consider instead of Merck KGaA.

Shares of Merck KGaA (OTCMKTS:MKGAF - Get Free Report) crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $129.40 and traded as low as $124.88. Merck KGaA shares last traded at $130.00, with a volume of 180 shares changing hands.

Merck KGaA Stock Performance

The stock's 50-day moving average price is $129.02 and its 200-day moving average price is $133.13. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The company has a market capitalization of $16.47 billion, a price-to-earnings ratio of 19.45 and a beta of 0.96.

About Merck KGaA

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Featured Articles

Should You Invest $1,000 in Merck KGaA Right Now?

Before you consider Merck KGaA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.

While Merck KGaA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.